Exploring research and treatment developments for colorectal cancer

CRC Network Meetings

Due to the ongoing pandemic the Organising Committee has postponed all meetings. We look forward to seeing friends and colleagues in the near future.

Please leave your contact details if you would like us to keep you posted on upcoming events.


The CRC Network is a partnership between two of the leading Universities in the UK and the Institute for Cancer Genetics and Informatics at Oslo University hospital.

logo of CRC Network partner, Oxford University logo Oslo University Hospital logo CRC network partner University College London, UCL

Previous meetings

2019

For the fourth Network meeting held in the end of March 2019, Stem cells and New Technologies were the topics. The beautiful Shulman auditorium at the Queen's College in Oxford was chosen as the meeting venue.

Link to pdf of lecture programme 2019

In March 2017 the third Network meeting was a joint event with the inauguration of the Oxford Centre for Cancer Gene Research. The meeting was hosted at the Queen's College in Oxford, with attendees from several countries, universities and research institutes.

Link to pdf of lecture programme 2017

The second CRC Network meeting was held in the historic surroundings of the Queen's College in Oxford, 19th - 20th March 2015.

Among the speakers were the founders of the CRC Network, as well as other researchers on colorectal cancer; Charles Swanton, Ragnhild A. Lohte, Ricky Sharma, Andrew Reynolds, Simon Leedham, Oliver Sieber, Enric Domingo, James M. Franklin, Anita Sveen, Arild Nesbakken and Bjørn Atle Bjørnbeth.

Link to pdf of lecture programme 2015

The very first network meeting was arranged at Oslo University Hospital, Radiumhospitalet, 5th September 2013, and the CRC Network was formally created. The seminar "Detecting and Managing Colorectal Cancer" was held in the new research building at The Norwegian Radium Hospital.

Link to pdf of lecture programme 2013

The Founders of the CRC Network

After many years collaboration, several studies and multiple papers on colorectal cancer, the four Professors decided in 2016 to establish the CRC Network. Getting together, learning from acknowledged experts, discussing face to face and sharing thoughts, ideas flourish and solutions for patients suffering from Colorectal cancer are explored.

Professor David Kerr

CBE MA MD DSc FRCP (Glas, Edin &Lon) FRCGP (Hon)FMedSci

Professor Marco Novelli

MBChB PhD FRCPath

Professor Ian Tomlinson

MA, PhD, BM, BCh FRCPath FMedSci

Professor Håvard E. Danielsen

PhD (Med), Leader of the CRC network

Support us

The CRC Network is an international network for researchers and medical personnell seeking a cure for colorectal cancer.

A donation will help us continue our task to discover better treatment options for patients with colorectal cancer.

We are certain our research has the power to make significant breakthroughs in diagnosis and treatment of this type of cancer. Our aim is to enable the best-equipped laboratories at our partner institutions, and to attract and inspire the best and brightest scientific minds to take on groundbreaking new research with the potential to prevent and enhance treatment for patients with colorectal cancer.

We thank our donors and supporters.

logo_CRCNetwork-Vipps-account

About Colorectal Cancer

Colorectal cancer is also known as colon cancer, rectal cancer or bowel cancer and is the development of cancer in the colon or rectum (parts of the large intestine).

Symptoms may include blood in the stool, a change in bowel movements, weight loss, and constant fatigue.

Risk factors for colorectal cancer include lifestyle, older age, and inherited genetic disorders. Other risk factors include diet, smoking, alcohol, lack of physical activity, family history of colon cancer and colon polyps, presence of colon polyps, race, exposure to radiation, and even other diseases such as diabetes and obesity. Genetic disorders only occur in a small fraction of the population. Other diseases such as inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, can increase the risk of colorectal cancer.

Bowel cancer may be diagnosed by obtaining a sample of the colon during a sigmoidoscopy or colonoscopy. Screening is recommended starting from the age of 50 to 75 and is effective for preventing and decreasing deaths from colorectal cancer.

Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery while cancer that has spread widely are usually not curable, with management focusing on improving quality of life and symptoms.

Globally, colorectal cancer is the third most common type of cancer making up about 10% of all cases. It is more common in developed countries, where more than 65% of cases are found, and less common in women than men.

illustration on colon cancer statistics illustration on colon cancer statistics illustration on colon cancer statistics

Contact

Are you interested in joining the next CRC Meeting, contributing as a speaker, would you like to know more about the research on colorectal cancer or would just like to get in touch? Please send us a note.

Radiumhospitalet
Ullernchausséen 66, Oslo